From laboratory to Phase I/II cancer trials with recombinant biotherapeutics.
Eur J Cancer. 2007 Nov;43(17):2515-22. doi: 10.1016/j.ejca.2007.08.027. Epub 2007 Oct 22.
Eur J Cancer. 2007.
PMID: 17933516
Review.